Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Different Conbercept Injection Methods in Treatment of Severe Proliferative Diabetic Retinopathy

NCT02816710 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT02816710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02816710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Different Conbercept Injection Methods in Treatment of Severe Proliferative Diabetic Retinopathy
Lead sponsor
Ruijin Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2016
Completion date
September 30, 2017
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy, tractional retinal detachment